Cartesian Therapeutics (1S70.MU) Q2 2026 Earnings

30AprConfirmed
Q2 2026
-1.24
-1.08
-0.91
-0.74

Details

Expected EPS
-0.7413092324999999
Actual EPS
-1.2443579999999999
Surprise EPS
-0.5
Surprise Percent
+67.86%

Description

Cartesian Therapeutics (1S70.MU) has reported earnings of -1.2443579999999999 per share for Q2 2026.

0 Comments

Share your thoughts